Skip to content

Fixation for the Treatment of Femoral Neck Fractures

the Fixation Method for the Treatment of Femoral Neck Fractures

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03550079
Enrollment
150
Registered
2018-06-08
Start date
2017-10-01
Completion date
2018-12-30
Last updated
2018-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Neck Fracture

Brief summary

The femoral neck fracture is the most prevalent injuries which commonly encountered among older people with high mortality, morbidity and young fit healthy ones who subjected to high-energy trauma . Non-union or avascular necrosis of femoral neck fracture which lead to loss of labor capacity and death, is the most commonly occurred complication and results in considerable burden for family. The treatment is difficult and challenging, and to minimize the negative results such as limited mobilization or other complications, it is essential to take active prevention and appropriate treatment depending on fracture pattern and patients' characteristics as early as possible. However, current implant selections for femoral neck fractures remain a topic of greater interest and controversy, and vary substantially from each other .

Detailed description

The incidence of femoral neck fracture accounts for 3.6% of all fractures, is the most prevalent injuries which commonly encountered among older people with high mortality, morbidity and young fit healthy ones who subjected to high-energy trauma . Non-union or avascular necrosis of femoral neck fracture which lead to loss of labor capacity and death, is the most commonly occurred complication and results in considerable burden for family. The treatment is difficult and challenging, and to minimize the negative results such as limited mobilization or other complications, it is essential to take active prevention and appropriate treatment depending on fracture pattern and patients' characteristics as early as possible. However, current implant selections for femoral neck fractures remain a topic of greater interest and controversy, and vary substantially from each other depending on the extent of displacement, fracture configuration, physiological age of the patient, bone quality or other relative factors. Nonoperative management is considered only when patients are seriously ill or presented with excessive surgical risk.

Interventions

PROCEDUREfixation

treated with different fixation method

Sponsors

Hebei Medical University Third Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* closed femoral neck fracture * no fractures at other sites * surgical treatment with cannulated compression screws or PFNA * follow-up time greater than 1 years.

Exclusion criteria

* the absence of severe cognitive dysfunction, * the presence of a pathological femoral neck fracture * previous femoral neck fracture, treated with other internal fixations and surgical treatment with open reduction.

Design outcomes

Primary

MeasureTime frameDescription
outcome measure were evaluated by femoral neck shortening with X raysup to 12 monthsfemoral neck shortening after 1 year with radiology measure,

Secondary

MeasureTime frameDescription
nonunionup to 12 monthsthe number of nonunion at the end of follow up in patients
screw-exitup to 12 monthsscrew-exit afer 1 year with X rays in all patients
cut-outup t 12 monthscut-out of the screw evaluating with x rays in all patients

Other

MeasureTime frameDescription
operative time in every patientintraoperationoutcome measure were evaluated by operative time
fluoroscopy time intraoperativelyintraoperationoutcome measure were evaluated by operative time and fluroscopy time

Countries

China

Contacts

Primary ContactZhang Yingze
dryzzhang@126.com18533112888
Backup ContactHou Zhiyong
drzyhou@gmail.com18533112800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026